You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2008 or most recent year available [see all tables in this series...]

Part (v) Inpatient clients by secondary drug and primary drug

Secondary drug	Amphetamines	MDMA and other derivatives
Secondary drug
Opioids	518	5
Cocaine	170	25
Cannabis	1181	46
Alcohol	528	22
Stimulants (other than cocaine)	173	20
Hypnotics and sedatives	436	13
Hallucinogens	93	8
Volatile	28	3
Other substances	45	4
Total number of citations	3172	146

Notes:

Clients may report one primary drug, but more than one secondary drug

Countries providing data are: BE, BG, CZ, DK, EE, IE, EL, ES, FR, IT, CY, LV, LU, HU, MT, NL, AT, RO, SI, SK, FI, SE, UK, TR

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2009 — Table TDI by centre type.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)